SER-109
Seres Therapeutics
['seres therap']
seres therapeutics and nestl health science present p-iii study (ecospor iv) results vowst for prevention of recurrence of c. difficile infection at ddw 2023 #clinicaltrials 
Real-time summarized News in 3 shots from pharma, biotech, medtech, digital health and life sciences industry readable in 60 seconds